Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05277857 · ClinicalTrials.gov registry record
Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome
A clinical trial of Nontuberculous Mycobacterial Lung Disease, sponsored by University of Virginia.
- Recruiting
- Registry status
- 720
- Enrollment target
- 1
- Study location
NCT05277857 is a study of Nontuberculous Mycobacterial Lung Disease that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 720 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05277857, a study of Nontuberculous Mycobacterial Lung Disease, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 720 participants
- Enrollment target
- 1
- Study location
Study Summary
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
Conditions Studied
Study Locations (1)
Virginia
- University of Virginia, Division of Infectious Disease - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2020-09-20 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05277857
The ClinicalTrials.gov registry entry for NCT05277857 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nontuberculous Mycobacterial Lung Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05277857 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05277857 about?
NCT05277857 is a clinical study titled "Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome". Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome
What is the current status of trial NCT05277857?
This trial is currently recruiting. The enrollment target is 720 participants. The study started on 2020-09-20. Estimated completion is 2026-12-31.
What conditions does trial NCT05277857 study?
This clinical trial studies the following conditions: Nontuberculous Mycobacterial Lung Disease.
Who is sponsoring clinical trial NCT05277857?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05277857 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nontuberculous Mycobacterial Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.